SequelSEC

GOLDENWELL BIOTECH, INC. GWLL

Food and Kindred Products · CIK 0001800373 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2026-06-30
Operating income
-$34.78K
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

GOLDENWELL BIOTECH, INC. (GWLL) reported revenue of $0 and net income of -$36.88K for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from GOLDENWELL BIOTECH, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Food and Kindred Products.

Income

GOLDENWELL BIOTECH, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$0$0$55$0$0$0$0$0$139$0
Cost of revenue$0$0$43$0$0$0$0$0$69$0
Gross profit$0$0$12$0$0$0$0$0$70$0
Operating income-$34.78K-$31.34K-$22.90K-$25.80K-$28.20K-$36.44K-$25.35K-$20.96K-$47.82K-$28.96K
Net income-$36.88K-$17.61K-$199.74K-$27.90K-$30.30K-$38.54K-$27.45K-$23.06K-$49.92K-$30.98K
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 99.00Mshares 99.00Mshares 99.00Mshares 96.43Mshares 99.00Mshares 99.00Mshares 99.00Mshares 96.43Mshares 96.43Mshares 99.00M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailable-$34.38KUnavailableUnavailableUnavailable-$31.06K
Income tax expense$0$0$0$0$0$0$0$0$0$0
Diluted EPS$0.00$0.00$0.00UnavailableUnavailable$0.00$0.00UnavailableUnavailable$0.00
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$34.78K$31.34K$22.91K$25.80K$28.20K$36.44K$25.35K$20.96K$47.89K$28.96K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

GOLDENWELL BIOTECH, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalentsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$25.72KUnavailable
Total assets$28.98K$18.75K$36.12K$233.76K$267.32K$191.92K$224.19K$179.43K$200.40K$198.97K
Current assetsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total liabilities$427.17K$380.07K$379.83K$377.73K$383.39K$277.69K$271.43K$198.67K$196.57K$145.22K
Current liabilities$100.00K$100.00K$101.86K$101.86K$109.62KUnavailable$1.86KUnavailableUnavailableUnavailable
Total equity incl. NCI-$398.20K-$361.32K-$343.71K-$143.97K-$116.08K-$85.78K-$47.24K-$20.90K$3.36K$53.28K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$0$0$174.74K$174.79K$174.79K$174.79K$174.79K$174.68K$174.68K$174.75K
Accounts receivableUnavailable$0Unavailable$0$0$0$0$0$0$0
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailable$176.08K$173.98KUnavailableUnavailableUnavailable
Accounts payable$0$0$0$0$0$0$0$0$0$0

Cash flow

GOLDENWELL BIOTECH, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$47.27K-$13.36K-$18.85K-$30.88K$59.38K-$32.28K-$25.35K-$20.96K-$47.75K-$29.01K
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Financing cash flow$45.00K$0$0$0$0$0$70.00K$0$49.25K$0
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

GOLDENWELL BIOTECH, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailable21.8%UnavailableUnavailableUnavailableUnavailableUnavailable50.4%Unavailable
Operating marginUnavailableUnavailable-41627.3%UnavailableUnavailableUnavailableUnavailableUnavailable-34402.9%Unavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratioUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Revenue YoY growthUnavailableUnavailableUnavailableUnavailable-100.0%Unavailable-100.0%-100.0%-49.6%-100.0%
Net marginUnavailableUnavailable-363163.6%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GWLL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-K · Filed 2026-07-01View SEC filing
10-Q · Filed 2026-07-01View SEC filing
10-Q/A · Filed 2026-06-29View SEC filing
10-Q/A · Filed 2026-06-26View SEC filing
10-Q/A · Filed 2026-06-26View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.